1-anilino-8-naphthalenesulfonate has been researched along with Muscle Weakness in 3 studies
1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.
Muscle Weakness: A vague complaint of debility, fatigue, or exhaustion attributable to weakness of various muscles. The weakness can be characterized as subacute or chronic, often progressive, and is a manifestation of many muscle and neuromuscular diseases. (From Wyngaarden et al., Cecil Textbook of Medicine, 19th ed, p2251)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nineteen consecutive LSM patients collected during 1995-2007 in our Neuromuscular Laboratory who were dramatically responsive to riboflavin and presented with proximal muscle weakness, exercise intolerance and elevated serum CK but without episodic encephalopathy were subjected to pathological, biochemical and molecular analysis." | 3.76 | Riboflavin-responsive lipid-storage myopathy caused by ETFDH gene mutations. ( Dai, T; Li, D; Li, H; Li, W; Liu, S; Wen, B; Wu, J; Yan, C; Zhang, C; Zhao, Y, 2010) |
| "Distal myopathy is a group of heterogeneous disorders affecting predominantly distal muscles usually appearing from young to late adulthood with very rare cardiac complications." | 1.35 | Distal lipid storage myopathy due to PNPLA2 mutation. ( Hayashi, YK; Malicdan, MC; Nishino, I; Noguchi, S; Nomura, K; Nonaka, I; Ohji, S; Ohkuma, A; Sugie, H, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ohkuma, A | 1 |
| Nonaka, I | 1 |
| Malicdan, MC | 1 |
| Noguchi, S | 1 |
| Ohji, S | 1 |
| Nomura, K | 1 |
| Sugie, H | 1 |
| Hayashi, YK | 1 |
| Nishino, I | 1 |
| Wen, B | 1 |
| Dai, T | 1 |
| Li, W | 1 |
| Zhao, Y | 1 |
| Liu, S | 1 |
| Zhang, C | 1 |
| Li, H | 1 |
| Wu, J | 1 |
| Li, D | 1 |
| Yan, C | 1 |
| Bruno, C | 1 |
| Bertini, E | 1 |
| Di Rocco, M | 1 |
| Cassandrini, D | 1 |
| Ruffa, G | 1 |
| De Toni, T | 1 |
| Seri, M | 1 |
| Spada, M | 1 |
| Li Volti, G | 1 |
| D'Amico, A | 1 |
| Trucco, F | 1 |
| Arca, M | 1 |
| Casali, C | 1 |
| Angelini, C | 1 |
| Dimauro, S | 1 |
| Minetti, C | 1 |
3 other studies available for 1-anilino-8-naphthalenesulfonate and Muscle Weakness
| Article | Year |
|---|---|
Distal lipid storage myopathy due to PNPLA2 mutation.
Topics: Adult; Atrophy; Cardiomyopathy, Dilated; Distal Myopathies; Hand; Humans; Leg; Lipase; Lipid Metabol | 2008 |
Riboflavin-responsive lipid-storage myopathy caused by ETFDH gene mutations.
Topics: Adolescent; Adult; Blotting, Western; Child; Electron-Transferring Flavoproteins; Female; Humans; Ir | 2010 |
Clinical and genetic characterization of Chanarin-Dorfman syndrome.
Topics: 1-Acylglycerol-3-Phosphate O-Acyltransferase; Adolescent; Adult; Child; Child, Preschool; DNA Mutati | 2008 |